Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Coya Therapeutics, Inc. (COYA) since 2023 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Coya Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1835022.
Total stock buying since 2023: $73,216.
Total stock sales since 2023: $0.
Total stock option exercises since 2023: $19,137.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 0 | $0 | 17,557 | $19,137 |
2024 | 9,510 | $69,596 | 0 | $0 | 0 | $0 |
2023 | 178,000 | $3,620 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-08 | 0 | $0 | 0 | $0 | 17,557 | $19,137 |
2024-11 | 9,510 | $69,596 | 0 | $0 | 0 | $0 |
2023-08 | 1,000 | $3,620 | 0 | $0 | 0 | $0 |
2023-01 | 177,000 | $0 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-08-18 | Goldstein Dov A Md | Option Ex | 17,557 | 1.09 | 19,137 |
2024-11-14 | Snyder David S (Chief Financial Officer) | Buy | 1,800 | 7.19 | 12,934 |
2024-11-11 | Swaminathan Arun (Chief Executive Officer) | Buy | 5,000 | 7.34 | 36,690 |
2024-11-11 | Grossman Fred (Chief Medical Officer) | Buy | 2,710 | 7.37 | 19,972 |
2023-08-22 | Lee Ann | Buy | 1,000 | 3.62 | 3,620 |
2023-01-03 | Lee Ann | Buy | 20,000 | .00 | 0 |
2023-01-03 | Berman Howard (Chief Executive Officer) | Buy | 20,000 | .00 | 0 |
2023-01-03 | Villalobos Anabella | Buy | 20,000 | .00 | 0 |
2023-01-03 | Garren Hideki | Buy | 4,000 | .00 | 0 |
2023-01-03 | Hepner Adrian (Chief Medical Officer) | Buy | 20,000 | .00 | 0 |
2023-01-03 | Snyder David S (Chief Financial Officer) | Buy | 14,000 | .00 | 0 |
2023-01-03 | Goldstein Dov A Md | Buy | 20,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of COYA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Coya Therapeutics, Inc. (symbol COYA, CIK number 1835022) see the Securities and Exchange Commission (SEC) website.